FIELD: medicine, endocrinology.
SUBSTANCE: invention proposes a medicinal agent for reducing the blood sugar content after food intake and representing a compound included in meglytinides and, if necessary, a pharmaceutically acceptable carrier. Nateglynide is the preferable compound. The complication associated with diabetes mellitus is chosen among nephropathy, retinopathy, neuropathy and angiopathy. At least one agent chosen among antihypertensive agent, vasodilating agent and antihyperlipidemic agent can be used with agent used simultaneously for reducing the blood content after food intake. Invention provides realization of indicated prescription.
EFFECT: valuable medicinal properties of drugs.
15 cl, 2 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHODS FOR TREATING DIABETES | 2004 |
|
RU2367423C2 |
| PANCREATIC DIABETES DRUG | 2004 |
|
RU2358738C2 |
| MATERIALS AND METHODS FOR METABOLISM MODULATION | 2005 |
|
RU2387445C2 |
| APPLICATION OF HYPOGLYCEMIC AGENT FOR TREATING AFFECTED GLUCOSE METABOLISM | 2000 |
|
RU2264811C2 |
| USE OF RKS INHIBITORS IN DIABETES RELATED COMPLICATIONS | 2007 |
|
RU2447892C2 |
| METHOD FOR TREATING METABOLISM DISORDERS MAINLY DIABETES CASES AND DISEASES OR STATES RELATED TO DIABETES | 2000 |
|
RU2280447C2 |
| COMBINATION FOR TREATMENT OF DIABETES AND COMPLICATIONS THEREOF | 2011 |
|
RU2451506C1 |
| AGENT FOR PROPHYLAXIS AND TREATMENT OF DIABETIC COMPLICATIONS | 1996 |
|
RU2173148C2 |
| METHOD OF IMPROVEMENT OF LIVER FUNCTION | 2013 |
|
RU2653478C2 |
| PHARMACEUTICAL COMBINATION CONTAINING SGLT2 INHIBITOR | 2008 |
|
RU2489151C2 |
